Clinicopathologic characteristics and outcomes to immune checkpoint inhibitor therapy in patients with HER2-altered metastatic non-small cell lung cancer

被引：0
|
作者：
Makarem, M. [1 ]
Ricciuti, B. [1 ]
Alessi, J. V. [1 ]
Pecci, F. [1 ]
Di Federico, A. [1 ]
Gandhi, M. [1 ]
Janne, P. A. [1 ]
Awad, M. M. [1 ]
Rotow, J. K. [1 ]
机构：
[1] Lowe Ctr Thorac Oncol, Dana Farber Canc Inst, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.980
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2198P
引用
收藏
页码：S1136 / S1136
页数：1
相关论文
共 50 条
  • [41] Outcomes with chemotherapy for metastatic non-small cell lung cancer (mNSCLC) in patients previously treated with immune checkpoint inhibitors (CPI).
    Elnair, Radowan
    Chang, Guy Vin
    Powell, Steven Francis
    Sumey, Christopher Joseph
    Bleeker, Jonathan Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Efficacy and outcomes of ramucirumab and docetaxel in patients with metastatic non-small cell lung cancer after disease progression on immune checkpoint inhibitor therapy: Results of a monocentric, retrospective analysis
    Kareff, Samuel A.
    Gawri, Kunal
    Khan, Khadeja
    Kwon, Deukwoo
    Rodriguez, Estelamari
    Lopes, Gilberto de Lima
    Dawar, Richa
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine, 2020, 17 (03) : 599 - 611
  • [44] Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease
    Sato, Yusuke
    Watanabe, Satoshi
    Ota, Takeshi
    Kushiro, Kohei
    Fujisaki, Toshiya
    Takahashi, Miho
    Ohtsubo, Aya
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Hokari, Satoshi
    Kondo, Rie
    Hayashi, Masachika
    Ishikawa, Hiroyuki
    Miyabayashi, Takao
    Abe, Tetsuya
    Miura, Satoru
    Tanaka, Hiroshi
    Okajima, Masaaki
    Terada, Masaki
    Ishida, Takashi
    Iwashima, Akira
    Sato, Kazuhiro
    Yoshizawa, Hirohisa
    Aoki, Nobumasa
    Ohshima, Yasuyoshi
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3132 - +
  • [45] Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer
    Chikaishi, Yasuhiro
    Inoue, Masaaki
    Kusanagi, Kasumi
    Honda, Yohei
    Yoshida, Junichi
    Tanaka, Masao
    AGING MEDICINE, 2021, 4 (01) : 42 - 46
  • [46] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine , 2020, (03) : 599 - 611
  • [47] Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients.
    Watanabe, Hiromi
    Kubo, Toshio
    Ninomiya, Kiichiro
    Minami, Daisuke
    Kudo, Kenichiro
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Zhai, Xiaoyang
    Zhang, Jian
    Tian, Yaru
    Li, Ji
    Jing, Wang
    Guo, Hongbo
    Zhu, Hui
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 599 - 611
  • [49] Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer
    Katayama, Yuki
    Shimamoto, Takayuki
    Yamada, Tadaaki
    Takeda, Takayuki
    Yamada, Takahiro
    Shiotsu, Shinsuke
    Chihara, Yusuke
    Hiranuma, Osamu
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [50] EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON-SMALL CELL LUNG CANCER PATIENTS
    Okamatsu, Yuki
    Inoue, Shigesato
    Utsumi, Takahiro
    Kayukawa, Takafumi
    Uryu, Kazuyasu
    Inoue, Katsuhiro
    Tsubouchi, Kazuya
    Harada, Taishi
    RESPIROLOGY, 2018, 23 : 286 - 286
12345